|
1
|
Anders HJ, Huber TB, Isermann B and
Schiffer M: CKD in diabetes: Diabetic kidney disease versus
nondiabetic kidney disease. Nat Rev Nephrol. 14:361–377. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kanwar YS, Wada J, Sun L, Xie P, Wallner
EI, Chen S, Chugh S and Danesh FR: Diabetic nephropathy: Mechanisms
of renal disease progression. Exp Biol Med (Maywood). 233:4–11.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reidy K, Kang HM, Hostetter T and Susztak
K: Molecular mechanisms of diabetic kidney disease. J Clin Invest.
124:2333–2340. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kato M and Natarajan R: Diabetic
nephropathy-emerging epigenetic mechanisms. Nat Rev Nephrol.
10:517–530. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen P, Shi Q, Xu X, Wang Y, Chen W and
Wang H: Quercetin suppresses NF-κB and MCP-1 expression in a high
glucose-induced human mesangial cell proliferation model. Int J Mol
Med. 30:119–125. 2012.PubMed/NCBI
|
|
6
|
Miller CG, Pozzi A, Zent R and
Schwarzbauer JE: Effects of high glucose on integrin activity and
fibronectin matrix assembly by mesangial cells. Mol Biol Cell.
25:2342–2350. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guan T, Gao Q, Chen P, Fu L, Zhao H, Zou Z
and Mei C: Effects of polycystin-1 N-terminal fragment fusion
protein on the proliferation and apoptosis of rat mesangial cells.
Mol Med Rep. 10:1626–1634. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao HD, Sun TM, Wang WJ, Mei CL, Xu CG,
Bing D, Xue FS, Zhang SZ and Li L: Evaluation of polycystin-1
N-terminal peptide on the proliferation and apoptosis of cystic
lining epithilial cells in human ADPKD. Chin J Nephrol. 21:664–668.
2005.
|
|
9
|
Schmidt-Ott KM and Barasch J:
WNT/β-catenin signaling in nephron progenitors and their epithelial
progeny. Kidney Int. 74:1004–1008. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Surendran K, Schiavi S and Hruska KA:
Wnt-dependent β-catenin signaling is activated after unilateral
ureteral obstruction, and recombinant secreted frizzled-related
protein 4 alters the progression of renal fibrosis. J Am Soc
Nephrol. 16:2373–2384. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Naves MA, Requiao-Moura LR, Soares MF,
Silva-Júnior JA, Mastroianni-Kirsztajn G and Teixeira VP: Podocyte
Wnt/β-catenin pathway is activated by integrin-linked kinase in
clinical and experimental focal segmental glomerulosclerosis. J
Nephrol. 25:401–409. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Z, Xu J, Xu P, Liu S and Yang Z:
Wnt/β-catenin signalling pathway mediates high glucose induced cell
injury through activation of TRPC6 in podocytes. Cell Prolif.
46:76–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiao L, Zhou D, Tan RJ, Fu H, Zhou L, Hou
FF and Liu Y: Sustained activation of wnt/β-Catenin signaling
drives AKI to CKD progression. J Am Soc Nephrol. 27:1727–1740.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He W, Kang YS, Dai C and Liu Y: Blockade
of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria
and kidney injury. J Am Soc Nephrol. 22:90–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang JY, Gao YB, Zhang N, Zou DW, Wang P,
Zhu ZY, Li JY, Zhou SN, Wang SC, Wang YY and Yang JK: miR-21
overexpression enhances TGF-β1-induced epithelial-to-mesenchymal
transition by target smad7 and aggravates renal damage in diabetic
nephropathy. Mol Cell Endocrinol. 392:163–172. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Burcelin R, Serino M, Chabo C,
Blasco-Baque V and Amar J: Gut microbiota and diabetes: From
pathogenesis to therapeutic perspective. Acta Diabetol. 48:257–273.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alvarez ML, Khosroheidari M, Eddy E and
Kiefer J: Role of microRNA 1207-5P and its host gene, the long
non-coding RNA Pvt1, as mediators of extracellular matrix
accumulation in the kidney: Implications for diabetic nephropathy.
PLoS One. 8:e774682013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li ZY, Zheng Y, Chen Y, Pan M, Zheng SB,
Huang W, Zhou ZH and Ye HY: Brazilin ameliorates diabetic
nephropathy and inflammation in db/db Mice. Inflammation.
40:1365–1374. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gurley SB, Ghosh S, Johnson SA, Azushima
K, Sakban RB, George SE, Maeda M, Meyer TW and Coffman TM:
Inflammation and immunity pathways regulate genetic susceptibility
to diabetic nephropathy. Diabetes. 67:2096–2106. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shaterzadeh-Yazdi H, Noorbakhsh MF,
Samarghandian S and Farkhondeh T: An overview on renoprotective
effects of Thymoquinone. Kidney Dis (Basel). 4:74–82. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen C, Gong W, Li C, Xiong F, Wang S,
Huang J, Wang Y, Chen Z, Chen Q and Liu P: Sphingosine kinase 1
mediates AGEs-induced fibronectin upregulation in diabetic
nephropathy. Oncotarget. 8:78660–78676. 2017.PubMed/NCBI
|
|
23
|
Xie X, Chen Q and Tao J: Astaxanthin
promotes Nrf2/ARE signaling to inhibit HG-induced renal fibrosis in
GMCs. Mar Drugs. 16(pii): E1172018.PubMed/NCBI
|
|
24
|
Wang J, Duan L, Guo T, Gao Y, Tian L, Liu
J, Wang S and Yang J: Downregulation of miR-30c promotes renal
fibrosis by target CTGF in diabetic nephropathy. J Diabetes
Complications. 30:406–414. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo Q, Zhong W, Duan A, Sun G, Cui W,
Zhuang X and Liu L: Protective or deleterious role of
Wnt/beta-catenin signaling in diabetic nephropathy: An unresolved
issue. Pharmacol Res. 144:151–157. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang L, Shen ZY, Wang K, Li W, Shi JM,
Osoro EK, Ullah N, Zhou Y and Ji SR: C-reactive protein exacerbates
epithelial-mesenchymal transition through Wnt/β-catenin and ERK
signaling in streptozocin-induced diabetic nephropathy. FASEB J.
33:6551–6563. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ali H, Zmuda JM, Cvejkus RK, Kershaw EE,
Kuipers AL, Oczypok EA, Wheeler V, Bunker CH and Miljkovic I: Wnt
pathway inhibitor DKK1: A potential novel biomarker for adiposity.
J Endocr Soc. 3:488–495. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lai M, Song X, Pluznick JL, Di Giovanni V,
Merrick DM, Rosenblum ND, Chauvet V, Gottardi CJ, Pei Y and Caplan
MJ: Polycystin-l C terminal tail associates with β-catenin and
inhibits canonical Wnt signaling. Hum Mol Genet. 17:3105–3117.
2008. View Article : Google Scholar : PubMed/NCBI
|
